Fig. 4
Kaplan–Meier curves for a progression-free survival and b duration of response in the overall population, and c progression-free survival in patients with prior daratumumab
Fig. 4 | Blood Cancer Journal
Kaplan–Meier curves for a progression-free survival and b duration of response in the overall population, and c progression-free survival in patients with prior daratumumab
